Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Harlé

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|October 13, 2019
Cell-Free DNA in the Management of Colorectal CancerAlexandre Harlé
Frontiers in Oncology|December 14, 2020
Pathology of HPV-Associated Head and Neck Carcinomas: Recent Data and Perspectives for the Development of Specific Tumor MarkersXavier Sastre-Garau, Alexandre Harlé
Annales De Biologie Clinique|November 16, 2013
[Response predictive biomarkers to targeted therapies in oncology]Alexandre Harlé, Jean-Louis Merlin
Cancers|April 3, 2021
Detection of Microsatellite Instability: State of the Art and Future Applications in Circulating Tumour DNA (ctDNA)Pauline Gilson, Jean-Louis Merlin, Alexandre Harlé
Cancers|March 25, 2022
Deciphering Tumour Heterogeneity: From Tissue to Liquid BiopsyPauline Gilson, Jean-Louis Merlin, Alexandre Harlé
The Journal of Molecular Diagnostics : JMD|October 4, 2020
Comparison of Pathogenicity Prediction Tools on Somatic VariantsVoreak Suybeng, Florence Koeppel, Alexandre Harlé, et al.
Bulletin Du Cancer|October 1, 2013
[Clinical, diagnostic significance and theranostic interest of PIK3CA gene mutations in breast cancer]Alexandre Harlé, Maëva Lion, Nicolas Lozano, et al.
Genes, Chromosomes & Cancer|September 29, 2018
Nuclear factor I X is a recurrent target for HPV16 insertions in anal carcinomasEmmanuelle Jeannot, Alexandre Harlé, Allyson Holmes, et al.
Annales De Biologie Clinique|October 12, 2013
[Method validation according to ISO 15189 and SH GTA 04: application for the detection of KRAS mutations using PCR TaqMan assay]Alexandre Harlé, Cindy Dubois, Marie Rouyer, et al.
Oncology Reports|August 1, 2013
Expression and activation of P38 MAP kinase in invasive ductal breast cancers: correlation with expression of the estrogen receptor, HER2 and downstream signaling phosphorylated proteinsJean-Louis Merlin, Alexandre Harlé, Maëva Lion, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|October 13, 2019
Cell-Free DNA in the Management of Colorectal CancerAlexandre Harlé
Frontiers in Oncology|December 14, 2020
Pathology of HPV-Associated Head and Neck Carcinomas: Recent Data and Perspectives for the Development of Specific Tumor MarkersXavier Sastre-Garau, Alexandre Harlé
Annales De Biologie Clinique|November 16, 2013
[Response predictive biomarkers to targeted therapies in oncology]Alexandre Harlé, Jean-Louis Merlin
Cancers|April 3, 2021
Detection of Microsatellite Instability: State of the Art and Future Applications in Circulating Tumour DNA (ctDNA)Pauline Gilson, Jean-Louis Merlin, Alexandre Harlé
Cancers|March 25, 2022
Deciphering Tumour Heterogeneity: From Tissue to Liquid BiopsyPauline Gilson, Jean-Louis Merlin, Alexandre Harlé
The Journal of Molecular Diagnostics : JMD|October 4, 2020
Comparison of Pathogenicity Prediction Tools on Somatic VariantsVoreak Suybeng, Florence Koeppel, Alexandre Harlé, et al.
Bulletin Du Cancer|October 1, 2013
[Clinical, diagnostic significance and theranostic interest of PIK3CA gene mutations in breast cancer]Alexandre Harlé, Maëva Lion, Nicolas Lozano, et al.
Genes, Chromosomes & Cancer|September 29, 2018
Nuclear factor I X is a recurrent target for HPV16 insertions in anal carcinomasEmmanuelle Jeannot, Alexandre Harlé, Allyson Holmes, et al.
Annales De Biologie Clinique|October 12, 2013
[Method validation according to ISO 15189 and SH GTA 04: application for the detection of KRAS mutations using PCR TaqMan assay]Alexandre Harlé, Cindy Dubois, Marie Rouyer, et al.
Oncology Reports|August 1, 2013
Expression and activation of P38 MAP kinase in invasive ductal breast cancers: correlation with expression of the estrogen receptor, HER2 and downstream signaling phosphorylated proteinsJean-Louis Merlin, Alexandre Harlé, Maëva Lion, et al.
Pageof 7